July 27, 2016
Recommended Topic Related To:

Fulyzaq

"The number of pregnant and breastfeeding women in Malawi with HIV who started life-saving antiretroviral treatment increased by more than 700 percent in one year, according to a study in CDC's Morbidity and Mortality Weekly Report. The "...

A A A

Fulyzaq

Indications
Dosage
How Supplied

INDICATIONS

FULYZAQ is indicated for symptomatic relief of non-infectious diarrhea in patients with HIV/AIDS on anti-retroviral therapy.

DOSAGE AND ADMINISTRATION

The recommended dose of FULYZAQ is one 125 mg delayedrelease tablet taken orally two times a day, with or without food. FULYZAQ tablets should not be crushed or chewed. Tablets should be swallowed whole.

HOW SUPPLIED

Dosage Forms And Strengths

FULYZAQ is a white, oval, enteric-coated 125 mg delayed-release tablet printed on one side with 125SLXP.

Storage And Handling

Crofelemer delayed-release tablets, 125 mg, are white, oval enteric-coated tablets printed on one side with 125SLXP. They are available in the following package size:

Bottles of 60: NDC 70564-802-02

Store at 20°C-25°C (68°F-77°F); excursions permitted between 15°C-30°C (59°F-86°F). See USP Controlled Room Temperature.

Manufactured by: Patheon, Inc. for Salix Pharmaceuticals, Inc., Raleigh, NC 27615. Revised: Feb 2013

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 4/14/2016

Indications
Dosage
How Supplied

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.